COVID-19

D-HH Chief Clinical Officer Edward J. Merrens, MD

D-HH Continues to Adapt to Rapidly Changing Health Care Landscape as COVID-19 Pandemic Rages On

National staffing crisis, pandemic resurgence have increased local impacts; health providers ask for understanding and patience as they make the best, difficult decisions to ensure excellent care

View story

COVID-19 vaccine

D-HH Answers Questions about Third COVID-19 Vaccine Dose for Immunocompromised People

The U.S. Food and Drug Administration (FDA) authorized the use of a third dose of the Pfizer and Moderna COVID-19 vaccines for immunocompromised people, with the third dose to be administered at least 28 days following the first two doses.

View story

The Cure Podcast

COVID-19 and Cancer: D-H Doctors Discuss Vaccine Safety for Cancer Patients on “The Cure Podcast”

Special guest, DHMC Interim Section Chief of Medical Oncology Gary N. Schwartz, MD.

View story